Jennifer Burstein
Director/Board Member at STOKE THERAPEUTICS, INC.
Net worth: - $ as of 30/03/2024
Profile
Ms. Jennifer C.
Burstein is a Senior Vice President-Finance Operations at Treeline Biosciences, Inc. and an Independent Director at Stoke Therapeutics, Inc. She is on the Board of Directors at Stoke Therapeutics, Inc. Ms. Burstein was previously employed as a Senior Vice President-Finance by Loxo Oncology, Inc., a Vice President-Finance by Acorda Therapeutics, Inc., and a Senior Director-Accounting by Oldtech, Inc. She received her undergraduate degree from State University of New York at Buffalo and an MBA from State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
STOKE THERAPEUTICS, INC.
-.--% | 31/08/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Jennifer Burstein active positions
| Companies | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Director/Board Member | 13/06/2019 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Corporate Officer/Principal | 28/02/2021 |
Former positions of Jennifer Burstein
| Companies | Position | End |
|---|---|---|
| LOXO ONCOLOGY INC | Director of Finance/CFO | 31/12/2018 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 29/04/2015 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Comptroller/Controller/Auditor | 31/12/2005 |
Training of Jennifer Burstein
| State University of New York at Buffalo | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Jennifer Burstein
